Based on its share price, down 75% in the last three years, it's easy to write off Moderna (NASDAQ: MRNA) as a biotech ...

Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

To reduce the spread of COVID-19, many countries have implemented measures such as lockdowns, travel restrictions, mask mandates, and social distancing guidelines. Vaccines have been developed and ...

In a move to bolster global health cooperation, China has pledged its unwavering support for the World Health Organization ...